Showing posts with label Food. Show all posts
Showing posts with label Food. Show all posts

Tuesday, August 10, 2010

Banning trans fats would save lives, say doctors

Moral of the story: In the end banning artificial trans fat would be a good public health measure.  Until that point you can try to avoid them on your own.

Source: BMJ Press Release


(3) Banning trans fats would save lives, say doctors
(Editorial: Removing industrial trans fat from foods)
http://www.bmj.com/cgi/content/full/340/apr15_1/c1826
Banning trans fats from all foods in the UK would prevent thousands of heart attacks and deaths every year, and would be a simple way to protect the public and save lives, say two senior doctors on bmj.comtoday.
Their views follow calls by public health specialists to eliminate the consumption of industrially-produced trans fats in the UK by next year.
Trans fats (also known as trans fatty acids) are solid fats found in margarines, biscuits, cakes, and fast food. Many studies demonstrate harmful effects of trans fats on cardiovascular risk factors.
For example, trans fats increase the amount of low density lipoprotein (LDL) or 'bad cholesterol' in the blood and reduce the amount of high density lipoprotein (HDL) or 'good cholesterol.' People with high levels of LDL cholesterol tend to have a higher risk of getting heart disease, while people with high levels of HDL cholesterol tend to have a lower risk.
A recent analysis of all the evidence recommended that people should reduce or stop their dietary intake of trans fatty acids to minimise the related risk of coronary heart disease.
The authors, from Harvard School of Public Health in the US, report that bans in Denmark and New York City effectively eliminated trans fats, without reducing food availability, taste, or affordability.
There is also no evidence that such legislation leads to harm from increased use of saturated fats.
Removing industrial trans fats is one of the most straightforward public health strategies for rapid improvements in health, they write. Based on current disease rates, a strategy to reduce consumption of trans fats by even 1% of total energy intake would be expected to prevent 11,000 heart attacks and 7,000 deaths annually in England alone.
Action by the UK might also produce larger benefits by inspiring other developed and developing countries to take similar measures to protect their citizens' health, they conclude.
Contact: Dariush Mozaffarian, Assistant Professor of Medicine and Epidemiology, Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
Email: dmozaffa@hsph.harvard.edu

Tuesday, August 3, 2010

Low-fat, low-carbohydrate diets may produce similar weight loss

Moral of the story: Obviously any diet that decreases energy eaten will help you lose weight.  The key difference is that low-carb diets increase your good (HDL) cholesterol.

Source: AMA Morning Rounds 8/3/2010


Low-fat, low-carbohydrate diets may produce similar weight loss.

USA Today (8/3, Hellmich) reports that low-fat and low-carbohydrate diets "produce similar weight loss and improvements in many health measures," according to a study sponsored by the National Institutes of Health and published Aug. 3 in the Annals of Internal Medicine. "To compare the two types of diet plans, researchers at three major medical centers tracked the weight loss of more than 300 obese people for two years. Half of participants followed a low-carb diet, consuming about 20 grams of carbohydrates a day for three months, then gradually increased their carb intake over time," while the other half "followed a low-calorie, low-fat diet of 1,200 to 1,800 calories a day, depending on their weight and gender, with less than 30% of calories from fat."
        "Both diets improved cholesterol in a two-year study" of 307 adults, the AP (8/3, Nano) reports. However, dieters "on the low-carbohydrate diet got a bigger boost in their so-called good cholesterol, nearly twice as much as those on low-fat." Specifically, "the key difference was in HDL, or good cholesterol: a 23 percent increase from low-carb dieting compared to a 12 percent improvement from low-fat, said" the study's lead author, who likened the improvement to "the kind one might get from medicines that improve HDL."
        The Los Angeles Times (8/2, Stein) "Booster Shots" blog reported that both groups of dieters "also took part in a two-year behavioral program that focused on how to manage relapses, self-monitoring, and an emphasis on moderate physical activity." Notably, "after two years, both groups had a 7% weight loss." Interestingly, the low-carb dieters also "had a substantially greater decrease in diastolic blood pressure...than did the low-fat group at three and six months," a difference that "still remained after two years."
        According to MedPage Today (8/2, Bankhead), "Participants in the low-carbohydrate group reported significantly more adverse effects, particularly during the first six to 12 months of the study. The low-carbohydrate diet was associated with more reports of bad breath, hair loss, constipation, and dry mouth." WebMD (8/2, Boyles), the CNN (8/2, Willingham) "The Chart" blog also covered the study.

Monday, July 26, 2010

False Positives Prevalent in Food Allergy Testing

Moral of the story: Lots of allergy testing is done either by blood tests or patch skin tests, both of which are NOT reliable.  Challenge tests are the best way to make sure you actually have to worry about your children eating peanuts.

Source: AMA Morning Rounds 7/23/2010


Study highlights prevalence of false positives in food allergy skin, blood tests.

The Chicago Tribune (7/24, Munz) reported, "Food allergies are often misdiagnosed, leaving many parents needlessly worrying about dangerous reactions and painstakingly monitoring food, said Dr. Leonard Bacharier, director of pediatric allergy and immunology at Washington University School of Medicine." One "key reason, he said, is many parents rely solely on the results of blood or skin tests, which are increasing in use because of easier access," yet, "experts agree blood and skin tests are not reliable." In fact, a recent study published in Journal of Allergy and Clinical Immunology found that 66 of "79 children who had positive skin or blood tests for peanut allergy" were actually not allergic.

Monday, June 7, 2010

Chefs improving school lunches- finally

Moral of the story: Chefs are finally starting to become involved in the fight against obesity.  Working with Michelle Obama they are starting an adopt a school program and are going to offer classes.  This is a very important first step, and as a former chef, I have to say a decidedly tardy but welcome one.

Source: AMA Morning Rounds 6/4/2010

Chefs aim to improve school lunches in DC, across the US.


The Washington Post (6/4, Black) reports that Washington, DC's Iron Chefs "have taken the first steps to make real the lofty goals of Michelle Obama's Let's Move! initiative, which aims to end childhood obesity within a generation." Some have begun "teaching cooking classes to hundreds of students and parents, and have helped to plant school gardens." On Friday, "hundreds of...chefs will gather at the White House to launch a national adopt-a-school program. Dubbed Chefs Move to Schools, the initiative will draw both the brightest stars of the culinary universe -- Rachael Ray, Tom Colicchio and Cat Cora -- and the unknown soldiers who staff corporate kitchens, food banks and culinary schools."
        In an editorial, the Houston Chronicle (6/4) mentions the meeting between Mrs. Obama and the chefs, and says, "It's a fun, flashy piece of the mom-in-chief's war on childhood obesity -- which is, sadly, a big fat American problem." Notably, "Houston is on the leading edge of the problem." Approximately "36 percent of our kids ages 6 to 17 are overweight; 19 percent are obese." But, according to the Chronicle, "we're also on the leading edge of the solution -- largely because of Recipe for Success, one of the biggest organizations battling childhood obesity. The nonprofit group runs after-school cooking and gardening classes, as well as summer camps."

Wednesday, January 6, 2010

High coffee, tea intake may reduce chances of developing type 2 diabetes

Moral of the story: Drinking coffee and tea reduces chances of developing type II (late onset) diabetes

Source: AMA Morning Rounds 12/15/09;  Arch Intern Med. 2009;169(22):2053-2063.


High coffee, tea intake may reduce chances of developing type 2 diabetes.


Bloomberg News (12/15, Gibson) reports that, according to a study published in the Archives of Internal Medicine, "drinking four cups of coffee, decaf, or tea daily can reduce the chances of getting type 2 diabetes by about 25 percent to 35 percent." Harvard University "researchers reviewed 18 studies of almost 500,000 people" and discovered that "for each cup of coffee people drank, their likelihood of getting diabetes dropped by seven percent."
        "Even better results were found for bigger coffee and tea consumers -- drinking three to four cups a day was associated with about a 25% reduced diabetes risk, compared with those who drank between none and two cups day," the Los Angeles Times (12/15, Stein) reports. In addition, investigators found "positive results with decaf coffee and tea." Specifically, those "who drank more than three to four cups of decaf a day had about a one-third lower risk than those who didn't drink any," while "tea drinkers who consumed more than three to four cups a day had about a one-fifth lower diabetes risk than non-tea drinkers."
        HealthDay (12/14, Gordon) and MedPage Today (12/14, Fiore) also covered the story.

Coffee, Decaffeinated Coffee, and Tea Consumption in Relation to Incident Type 2 Diabetes Mellitus
A Systematic Review With Meta-analysis
Rachel Huxley, DPhil; Crystal Man Ying Lee, PhD; Federica Barzi, PhD; Leif Timmermeister; Sebastien Czernichow, MD, PhD; Vlado Perkovic, MD, PhD; Diederick E. Grobbee, MD, PhD; David Batty, PhD; Mark Woodward, PhD



Background  Coffee consumption has been reported to be inversely associated with risk of type 2 diabetes mellitus. Similar associations have also been reported for decaffeinated coffee and tea. We report herein the findings of meta-analyses for the association between coffee, decaffeinated coffee, and tea consumption with risk of diabetes.
Methods  Relevant studies were identified through search engines using a combined text word and MeSH (Medical Subject Headings) search strategy. Prospective studies that reported an estimate of the association between coffee, decaffeinated coffee, or tea with incident diabetes between 1966 and July 2009.
Results  Data from 18 studies with information on 457 922 participants reported on the association between coffee consumption and diabetes. Six (N = 225 516) and 7 studies (N = 286 701) also reported estimates of the association between decaffeinated coffee and tea with diabetes, respectively. We found an inverse log-linear relationship between coffee consumption and subsequent risk of diabetes such that every additional cup of coffee consumed in a day was associated with a 7% reduction in the excess risk of diabetes relative risk, 0.93 [95% confidence interval, 0.91-0.95]) after adjustment for potential confounders.
Conclusions  Owing to the presence of small-study bias, our results may represent an overestimate of the true magnitude of the association. Similar significant and inverse associations were observed with decaffeinated coffee and tea and risk of incident diabetes. High intakes of coffee, decaffeinated coffee, and tea are associated with reduced risk of diabetes. The putative protective effects of these beverages warrant further investigation in randomized trials.

Author Affiliations: The George Institute for International Health, The University of Sydney, Sydney, Australia (Drs Huxley, Lee, Barzi, Czernichow, Perkovic, Batty, and Woodward and Mr Timmermeister); Department of Public Health, Avicenne Hospital, University of Paris 13, Paris, France (Dr Czernichow); The Julius Center for Health Sciences and Primary Care, Utrecht University Medical Center, Utrecht, the Netherlands (Dr Grobbee); Medical Research Council Social & Public Health Sciences Unit, University of Glasgow, Glasgow, Scotland (Dr Batty); and Mount Sinai School of Medicine, New York, New York (Dr Woodward).

Sunday, November 29, 2009

Scientists find link between gut microbiota, diet, and weight gain.

Moral of the story: What you eat matters. A lot. The link between diet and weight is rather complicated and taking out fats and sugars can help to change the fauna of your stomach to help you lose weight. Chewing gum and breastfeeding help shed pounds too.

Source: AMA Morning Rounds 11/12/09

Scientists find link between gut microbiota, diet, and weight gain.

The Los Angeles Times (11/12, Maugh) reported, "A high-fat, high-sugar diet does more than pump calories into your body. It also alters the composition of bacteria in your intestines, making it easier to gain weight and harder to lose it," according to a new paper in Science Translational Medicine. What's more, the "changeover can happen in as little as 24 hours."

Technically known "as the gut microbiota," intestinal "microbes perform a vast range of vital functions, including helping to regulate the calories the body obtains from food and stores as fat," according to Time (11/12, Park). Through earlier experiments, however, Washington University researchers found that the "gut microbiota of obese mice...have significantly more of one main type of bacteria called Firmicutes, and fewer of another kind called Bacteroidetes (both types populate human guts as well); in normal mice, the distribution is the opposite." With that in mind, the team devised a new study in which human microbiota was used "to colonize mice guts." The rodents were then fed "equivalents of typical human diets to see how their microbes -- and their weight -- might change."

Lead investigator Dr. Jeffrey I. Gordon told HealthDay (11/11, Gordon) that when his team "switched these humanized animals [from a low-fat] to a junk-food diet, high in fat with lots of simple sugars, the structure of the microbial community changed dramatically and very rapidly." What's more, the mice "became obese on Western diets." Investigators also discovered that "the microbiota passes from generation to generation."

Study points to chewing gum as weight loss aid. The Washington Post (11/11, Huget) reports that for anybody trying to lose weight, "taking up gum-chewing might not be a bad idea," as "there's actually a bit of scientific evidence showing that chewing gum helps fight fat in a number of ways." The research, sponsored by the Wrigley Science Institute, has suggested "that chewing gum may help reduce cravings, particularly for sweet snacks, and spur people to cut their daily intake by about 50 calories." The findings were presented at the annual scientific meeting of the Obesity Society last month, and "showed that gum-chewing people consumed 67 fewer calories at lunch and didn't compensate by eating more later in the day."

Breastfeeding's effect on postpartum weight discussed. The New York Times (11/12, E3, Louis) reports, "That breastfeeding gives mothers an edge shedding baby weight has long been suspected." A Danish study published last year showed that "the more a mother breast-feeds, the less weight she retains six months after birth." But, other research has shown that "breast-feeders don't necessarily shed fat quicker than women who feed their newborns formula." Meanwhile, "a small double-blind randomized study conducted at Cincinnati Children's Hospital Medical Center found that non-lactating women lost more body fat than lactating women at six months, and at a faster rate." Still, "others suggest that women who view breast-feeding as a dieting tool may have 'deeper body issues.'" One expert said "she was troubled by our cultural preoccupation with postpartum weight."

Dark chocolate may lower stress hormone levels.

Moral of the story: Every wonder why dark chocolate makes you feel better? It changes your stress hormone metabolism. Cool.

Source: AMA Morning Rounds 11/13/09

Dark chocolate may lower stress hormone levels.

HealthDay (11/12, Dotinga) reported that "a dose of dark chocolate could cheer you right up by lowering your stress hormone levels," according to a study published online in the Journal of Proteome Research. After following 30 "volunteers who said they were highly stressed," researchers found that "a daily consumption of 40 grams [1.4 ounces] during a period of two weeks is sufficient to modify the metabolism of healthy human volunteers" by helping "correct other imbalances in the body that are related to stress." Reuters (11/13, Goldsmith) and also covers the story.

Researchers associate low levels of vitamin D with CAD, stroke, heart failure.

Moral of the story: There is a link between the chronic, prevalent low vitamin D levels in the US and all those cardiovascular problems. It may be a tough balance between skin cancer and vitamin D, but the importance of the vitamin D is becoming more clear.

Source: AMA Morning Rounds 11/17/09

Researchers associate low levels of vitamin D with CAD, stroke, heart failure.

The New York Times (11/16, Rabin) "Well" blog reported that, according to research presented Nov. 16 at the American Heart Association conference, "Americans aren't getting anywhere nearly enough of" vitamin D, "and it may be affecting their heart health." After examining data on 27,686 "healthy adults 50 and older whose vitamin D levels had been measured during routine checkups," researchers found that "those who had extremely low levels of the vitamin were almost twice as likely to have died or suffered a stroke than those with adequate amounts." In addition, they "had more coronary artery disease and were twice as likely to have developed heart failure." HealthDay (11/16, Preidt) and CNN (11/17, Mann) also cover the study.

High salt intake directly linked to stroke and cardiovascular disease

Moral of the story: Eat less salt. That's it. Your heart will thank you.

Source: BMJ press releases Monday 23 November to Friday 27 November 2009. Available in full at www.bmj.com

(1) High salt intake directly linked to stroke and cardiovascular disease

(Research: Salt intake, stroke, and cardiovascular disease: meta-analysis of prospective studies)
http://www.bmj.com/cgi/doi/10.1136/bmj.b4336
(Editorial: The case for population-wide salt reduction gets stronge)
http://www.bmj.com/cgi/doi/10.1136/bmj.b4336

High salt intake is associated with significantly greater risk of both stroke and cardiovascular disease, concludes a study published on bmj.com today.

The link between high salt intake and high blood pressure is well established, and it has been suggested that a population-wide reduction in dietary salt intake has the potential to substantially reduce the levels of cardiovascular disease.

The World Health Organization recommended level of salt consumption is 5 g (about one teaspoon) per day at the population level, yet dietary salt intake in most Western countries is close to 10g per day (and much higher in many Eastern European countries).

Collaborative research conducted by Professor Pasquale Strazzullo at the University of Naples, Italy and Professor Francesco Cappuccio at the University of Warwick, UK analysed the results of 13 published studies involving over 170,000 people that directly assessed the relationship between levels of habitual salt intake and rates of stroke and cardiovascular disease.

Differences in study design and quality were taken into account to minimise bias.

Their analysis shows unequivocally that a difference of 5 g a day in habitual salt intake is associated with a 23% difference in the rate of stroke and a 17% difference in the rate of total cardiovascular disease.

Based on these results, the authors estimate that reducing daily salt intake by 5 g at the population level could avert one and a quarter million deaths from stroke and almost three million deaths from cardiovascular disease each year. Furthermore, because of imprecision in measurement of salt intake, these effect sizes are likely to be underestimated, say the authors.

These results support the role of a substantial population reduction in salt intake for the prevention of cardiovascular disease, they conclude.

This study is a useful and welcome addition to the medical literature, and strengthens the case for population-wide salt reduction, says Professor Lawrence Appel from Johns Hopkins University, in an accompanying editorial.

Contacts:
Research: Pasquale Strazzullo, Professor of Medicine, Department of Clinical and Experimental Medicine, "Federico II" ESH Excellence Centre of Hypertension, University of Naples Medical School, Naples, Italy
Email: strazzul@unina.it

Editorial: Lawrence Appel, Professor of Medicine (via Stephanie Desmon, Senior Media Relations Representative), Johns Hopkins University, Baltimore, MD, USA
Email: sdesmon1@jhmi.edu

Friday, June 26, 2009

Longer life linked to specific foods in Mediterranean diet

Moral of the story: More evidence that certains foods in the mediterranean diet are really good for you. Note the information on fish, meat, cereals and dairy.

An article summary from the British Medical Journal:

(2) Longer life linked to specific foods in Mediterranean diet(Research: Anatomy of the health effects of the Mediterranean diet, The Greek EPIC prospective cohort study)
http://www.bmj.com/cgi/doi/10.1136/bmj.b2175
Some food groups in the Mediterranean diet are more important than others in promoting health and longer life according to new research published on bmj.com today.
Eating more vegetables, fruits, nuts, pulses and olive oil, and drinking moderate amounts of alcohol, while not consuming a lot of meat or excessive amounts of alcohol is linked to people living longer.
However, the study also claims, that following a Mediterranean diet high in fish, seafood and cereals and low in dairy products were not indicators of longevity.
While several studies have concluded that the Mediterranean diet improves chances of living longer, this is the first to investigate the importance of individual components of the diet.
Professor Dimitrios Trichopoulos at the Harvard School of Public Health explains that they have surveyed over 23,000 men and women who were participants in the Greek segment of the European Prospective Investigation into Cancer and Nutrition (EPIC).
Participants were given dietary and lifestyle questionnaires when they enrolled onto the study and they were subsequently followed up for around 8.5 years with interviews. Their diets were rated from 0 to 10 based on the level of conformity to a traditional Mediterranean diet.
As part of the interview process, participants were also asked about their smoking status, levels of physical activity and whether they had ever been diagnosed with cancer, diabetes and heart disease.

The authors maintain that when high intake of vegetables, low intake of meat or moderate alcohol intake were excluded from the rating system, the benefits of following a Mediterranean diet were substantially reduced. They also note that there are clear benefits in combining several of the key components, for example high consumption of vegetables and olive oil.
Professor Trichopoulou, lead author of the study, concludes that the main reasons why the Mediterranean diet can lead to living longer are moderate consumption of ethanol (mostly in the form of wine during meals, as traditionally done in the Mediterranean countries), low consumption of meat and meat products, and high consumption of vegetables, fruits and nuts, olive oil and legumes.
Contacts: Professor Dimitrios Trichopoulos, Harvard School of Public Health, Boston, USAEmail: dtrichop@hsph.harvard.edu OrProfessor Antonia Trichopoulou, University of Athens Medical School, Athens, GreeceEmail: http://www.bmj.com/cgi/doi/10.1136/bmj.b2337

Wednesday, May 13, 2009

Cancer Patients Challenge the Patenting of a Gene

Moral of the story: Patents on genes are creating controversy and in the name of free speech and medical necessity need to be restricted. They are creating undue burden for patients because of the lack of market forces preventing innovating and driving up costs. As the article states, my genes can no more ethically be patented than my left arm or my brain. The laws need to change and reflect this reality. At the same time, genetically modified foods need to be revisited as the ethics of genetic patents are reviewed. It may be time to stop bowing to argibusiness and start fighting for every American.

http://www.nytimes.com/2009/05/13/health/13patent.html?em

Cancer Patients Challenge the Patenting of a Gene

Published: May 12, 2009

When Genae Girard received a diagnosis of breast cancer in 2006, she knew she would be facing medical challenges and high expenses. But she did not expect to run into patent problems.

Benjamin Sklar for The New York Times

Genae Girard, 39, is suing Myriad Genetics and the Patent Office over the granting of a patent on a gene. Myriad also has patented the only test that measures the risk of breast and ovarian cancer.

Ms. Girard took a genetic test to see if her genes also put her at increased risk for ovarian cancer, which might require the removal of her ovaries. The test came back positive, so she wanted a second opinion from another test. But there can be no second opinion. A decision by the government more than 10 years ago allowed a single company, Myriad Genetics, to own the patent on two genes that are closely associated with increased risk for breast cancer and ovarian cancer, and on the testing that measures that risk.

On Tuesday, Ms. Girard, 39, who lives in the Austin, Tex., area, filed a lawsuit against Myriad and the Patent Office, challenging the decision to grant a patent on a gene to Myriad and companies like it. She was joined by four other cancer patients, by professional organizations of pathologists with more than 100,000 members and by several individual pathologists and genetic researchers.

The lawsuit, believed to be the first of its kind, was organized by the American Civil Liberties Union and filed in federal court in New York. It blends patent law, medical science, breast cancer activism and an unusual civil liberties argument in ways that could make it a landmark case.

Companies like Myriad, based in Salt Lake City, have argued that the patent system promotes innovation by giving companies the temporary monopoly that rewards their substantial investment in research and development.

Richard Marsh, Myriad’s general counsel, said company officials would not be able to comment on the lawsuit until they had fully reviewed the complaint.

The coalition of plaintiffs argues that gene patents actually restrict the practice of medicine and new research.

“With a sole provider, there’s mediocrity,” said Wendy K. Chung, the director of clinical genetics at Columbia University and a plaintiff in the case.

Dr. Chung and others involved with the suit do not accuse Myriad of being a poor steward of the information concerning the two genes at issue in the suit, known as BRCA1 and BRCA2, but they argue that BRCA testing would improve if market forces were allowed to work.

Harry Ostrer, director of the human genetics program at the New York University School of Medicine and a plaintiff in the case, said that many laboratories could perform the BRCA tests faster than Myriad, and for less money than the more than $3,000 the company charged.

Laboratories like his, he said, could focus on the mysteries still unsolved in gene variants. But if he tried to offer such services today, he said, he would be risking a patent infringement lawsuit from Myriad.

Christopher A. Hansen, senior national staff counsel for the civil liberties union, said the problem was with the patent office, not the company. He recalled that when he first heard that the office had granted a patent for a gene, “I said that can’t be true.”

As the A.C.L.U. explored the restrictions on competition that companies like Myriad had put in place — blocking alternatives to the patented tests, and even the practice of interpreting or comparing gene sequences that involved those genes — the restrictions started to look like not just a question of patent law, Mr. Hansen said, but of the First Amendment’s guarantee of free speech as well.

“What they have really patented,” he said, “is knowledge.”

A patent was also granted to a single company for genetic testing on long QT syndrome, which can lead to heart arrhythmias and sudden death, and to the HFE gene, linked to hereditary hemochromatosis, a condition in which iron accumulates in the blood and can cause organ damage. Doctors and scientists have complained about both patents.

On the other hand, the company that owns the patent to the gene CFTR, which has been linked to cystic fibrosis, has licensed the testing to dozens of laboratories, drawing praise from the medical world.

The decision to allow gene patents was controversial from the start; patents are normally not granted for products of nature or laws of nature. The companies successfully argued that they had done something that made the genes more than nature’s work: they had isolated and purified the DNA, and thus had patented something they had created — even though it corresponded to the sequence of an actual gene.

The argument may have convinced patent examiners, but it has long been a sore point for many scientists. “You can’t patent my DNA, any more than you can patent my right arm, or patent my blood,” said Jan A. Nowak, president of the Association for Molecular Pathology, a plaintiff in the case.

So far, however, two panels of government experts who have looked at the issue have not found significant impediments to research or medical care caused by gene patents. A 2006 report from the National Research Council found that patented biomedical research “rarely imposes a significant burden for biomedical researchers.”

That report and others, however, warn that the patent landscape “could become considerably more complex and burdensome over time.”

In the future, genetic tests are likely to involve the analysis of many genes at once, or even of a person’s full set of genes. Some 20 percent of the human genome is already included in patent claims, amounting to thousands of individual genes, says a draft report from the National Institutes of Health. The report warns that “it may be difficult for any one developer to obtain all the needed licenses” to develop the next generations of tests.

For Lisbeth Ceriani, a single mother from Newton, Mass., and a plaintiff in the case against Myriad, the biggest obstacle that gene patents present is one of cost. She has had breast cancer and a double mastectomy, but wants to have BRCA testing to determine her risk of ovarian cancer and help her decide whether to have her ovaries removed. But Myriad has refused to work with her insurance plan, Mass Health, and paying for the test herself is beyond her means.

She is reluctant to have surgery that might prove unnecessary, she said, but she also worries about her 8-year-old daughter and the inherited risk she might face. Which is why, Ms. Ceriani said, she wants to “find out if I have the mutation, so I can take the necessary steps to stay on the planet.”

“I want to be here,” she said, “to make sure she does her screening by the time she’s 30.”

Tuesday, May 12, 2009

One Fish, Two Fish, Fish You Want to Buy, Fish You Never Want to Die

Moral of the story: We all know we are supposed to eat more fish. It is a diet rich is omega-3 fatty acids and low in more harmful fats. Yet at the same time we are constantly reminded of the terrible overfishing going on around the world. This website will help you select the most eco-friendly fish to help keep you healthy.

http://www.edf.org/page.cfm?tagID=1521

The website is easy to use, has recipes and health information along with lists of what fish to eat and which ones to avoid. Highly recommended.

Thursday, April 16, 2009

heart-health benefits from a Mediterranean diet

Moral of the story: Time and again the Mediterranean diet is proven to be a healthy eating option. This meta-analysis (aggregates all the previous studies) finalizes the debate, if there ever was one. Time to break out the fish and olives, but remember to eat sustainably, we want everyone to be able to enjoy these health benefits many years from now.

Heartwire: Prevention
Meta-analysis supports heart-health benefits from a Mediterranean diet
April 16, 2009 | Marlene Busko

Hamilton, ON - Strong evidence supports the protective effect of a Mediterranean diet on risk of CHD, and overall diet pattern appears more important than individual foods [1].

These findings, from a review of close to 200 studies, are published in the April 13, 2009 issue of the Archives of Internal Medicine.

"We found strong evidence that a 'Western' diet—which is high in processed meats, red meats, butter, eggs, refined grains, and high-fat dairy products—is associated with an increased risk of CAD, so we could say [to patients]: 'You should consume less of those types of foods and gravitate more toward a "prudent" diet or a Mediterranean diet, which are both high in fruits and vegetables, legumes, whole grains, and fish,' " senior author Dr Sonia Anand (McMaster University, Hamilton, ON) told heartwire.

Although this message is not really new, what is new is the way that this review assessed the strength of the evidence, she noted.

The study also found strong evidence of increased CHD risk from consuming trans-fatty acids and foods with a high glycemic index such as white potatoes, sugar, white rice, and white bread.

Physicians should advise patients: "Lower your trans-fats, lower your saturated fats, but also watch for some of these simple carbohydrates, because they can have adverse effects as well,'' said Anand.


Diet dilemma

The relationship between diet and CHD has been studied for decades, yet there is still some confusion about which foods or diets are best, since cohort studies and randomized controlled trials have often produced discrepant results, the researchers write.

To examine the strength of the evidence supporting a causal link between diet and CHD, the researchers reviewed 146 prospective cohort studies and 43 randomized controlled trials (RCTs).

Studies were scored on how well they met four criteria of strength, consistency, temporality, and coherence. A score of 4 was considered strong evidence of a cause-and-effect relationship between dietary exposure and disease.


Dietary pattern vs single food

In the cohort studies, a Mediterranean diet—characterized by higher intake of vegetables, legumes, fruits, nuts, whole grains, cheese or yogurt, fish, and monounsaturated as opposed to saturated fatty acids—and a "prudent diet"—characterized by high intake of vegetables, fruit, legumes, whole grains, fish, and other seafood—were each associated with significantly lower risk of CHD. Similarly, strong evidence supported the benefits from monounsaturated fatty acids and foods such as vegetables and nuts and the harm from trans-fatty acids and foods with a high glycemic index.

In the RCTs, however, only the Mediterranean diet was strongly linked to risk of CHD.

"Our findings support the strategy of investigating dietary patterns in cohort studies and RCTs for common and chronic complex diseases such as CHD," the researchers write.


Study reinforces heart-healthy diet

Commenting on the results for heartwire, Dr Robert Eckel (University of Colorado, Denver) said that the study confirms previous notions about what a heart-healthy diet is all about.

It's not a matter of good foods and bad foods. It's what the overall quality of the diet is.

"I think cardiologists need to increasingly make lifestyle-related issues an important part of their practice," he added. "This is another article reinforcing that a heart-healthy diet contains certain constituents and avoids certain constituents."

Concurring with the study authors, he noted: "Overall, the dietary pattern is what needs to be emphasized. It's not a matter of good foods and bad foods. It's what the overall quality of the diet is. The Western pattern is high in saturated fat, trans-fat, and cholesterol, whereas a Mediterranean diet and 'prudent' diet include more monounsaturated or polyunsaturated fats, and there is more fish consumption."

No financial disclosures were reported.
Source
  1. Mente A, de Koning L, Shannon HS, et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009; 169:659-669.

Wednesday, March 25, 2009

Childhood Behavioral Problems Predict Young Adults' BMI and Obesity

Moral of the story: Behavioral problems predict weight gain later in life. Simply be aware of this connection and monitor weight carefully in children with behavioral problems. Make sure they exercise and eat healthy. If you have a diagnosed behavior issue, get on that treadmill!

Epidemiology

Obesity (2009) 17 4, 761–766. doi:10.1038/oby.2008.594

Childhood Behavioral Problems Predict Young Adults' BMI and Obesity: Evidence From a Birth Cohort Study

Abdullah A. Mamun1, Michael J. O'Callaghan2, Susanna M. Cramb1, Jake M. Najman1, Gail M. Williams1 and William Bor3

  1. 1Longitudinal Studies Unit, School of Population Health, University of Queensland, Brisbane, Queensland, Australia
  2. 2Child Development and Rehabilitation Services, Mater Children's Hospital, Brisbane, Queensland, Australia
  3. 3The Mater Centre for Service Research in Mental Health, Department of Psychiatry, University of Queensland, Brisbane, Queensland, Australia

Correspondence: Abdullah A. Mamun (mamun@sph.uq.edu.au)

Received 21 September 2007; Accepted 2 September 2008; Published online 15 January 2009.

Abstract

We examined whether behavioral problems in childhood and adolescence are associated with young adults' BMI and obesity, and tested whether childhood behavioral problems have a greater impact on young adults' obesity than adolescent behavioral problems. The data were from the Mater-University of Queensland Study of Pregnancy (MUSP) and Its Outcomes, a population-based birth cohort study commenced in Brisbane, Australia, in 1981. A subsample of 2,278 children for whom we had prospective information on their behavioral problems at ages 5 and 14 and measured BMI, and its categories (normal, overweight, and obese) at age 21 was chosen. Young adults who experienced behavioral problems at ages 5 or 14 had a greater average BMI and were more likely to be obese compared to young adults without behavioral problems at both ages. The childhood onset group was at greater risk of becoming obese by age 21 compared to the adolescent onset group (P = 0.04). These associations remained consistent after adjusting for a variety of potential covariates including maternal characteristics (i.e., demographics and life style), child dietary patterns, family meals, television (TV) watching, and participation in sports and exercise at 14 years. Childhood as well as persistent behavioral problems during childhood and adolescence predicts young adults' BMI and obesity. Although further studies are needed to confirm this association, there is a need for close monitoring of children presenting with behavioral problems.

Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates

Moral of the story: Eat less, exercise more. Do not try a new fad diet because it supposedly is the best for losing weight. Pick a diet that will make you eat healthier, less food and you will actually like and adhere to. The type of diet doesn't actually matter for losing weight.

Comparison of Weight-Loss Diets with Different Compositions of Fat, Protein, and Carbohydrates
Frank M. Sacks, M.D., George A. Bray, M.D., Vincent J. Carey, Ph.D., Steven R. Smith, M.D., Donna H. Ryan, M.D., Stephen D. Anton, Ph.D., Katherine McManus, M.S., R.D., Catherine M. Champagne, Ph.D., Louise M. Bishop, M.S., R.D., Nancy Laranjo, B.A., Meryl S. Leboff, M.D., Jennifer C. Rood, Ph.D., Lilian de Jonge, Ph.D., Frank L. Greenway, M.D., Catherine M. Loria, Ph.D., Eva Obarzanek, Ph.D., and Donald A. Williamson, Ph.D.


ABSTRACT

Background The possible advantage for weight loss of a diet that emphasizes protein, fat, or carbohydrates has not been established, and there are few studies that extend beyond 1 year.

Methods We randomly assigned 811 overweight adults to one of four diets; the targeted percentages of energy derived from fat, protein, and carbohydrates in the four diets were 20, 15, and 65%; 20, 25, and 55%; 40, 15, and 45%; and 40, 25, and 35%. The diets consisted of similar foods and met guidelines for cardiovascular health. The participants were offered group and individual instructional sessions for 2 years. The primary outcome was the change in body weight after 2 years in two-by-two factorial comparisons of low fat versus high fat and average protein versus high protein and in the comparison of highest and lowest carbohydrate content.

Results At 6 months, participants assigned to each diet had lost an average of 6 kg, which represented 7% of their initial weight; they began to regain weight after 12 months. By 2 years, weight loss remained similar in those who were assigned to a diet with 15% protein and those assigned to a diet with 25% protein (3.0 and 3.6 kg, respectively); in those assigned to a diet with 20% fat and those assigned to a diet with 40% fat (3.3 kg for both groups); and in those assigned to a diet with 65% carbohydrates and those assigned to a diet with 35% carbohydrates (2.9 and 3.4 kg, respectively) (P>0.20 for all comparisons). Among the 80% of participants who completed the trial, the average weight loss was 4 kg; 14 to 15% of the participants had a reduction of at least 10% of their initial body weight. Satiety, hunger, satisfaction with the diet, and attendance at group sessions were similar for all diets; attendance was strongly associated with weight loss (0.2 kg per session attended). The diets improved lipid-related risk factors and fasting insulin levels.

Conclusions Reduced-calorie diets result in clinically meaningful weight loss regardless of which macronutrients they emphasize. (ClinicalTrials.gov number, NCT00072995 [ClinicalTrials.gov] .)

NEJM february 26, 2009 vol. 360 no. 9

Monday, March 23, 2009

Depression and antidepressant use linked to sudden cardiac death

Moral of the story: You may want to stay on the antidepressants, but knowing your risks can help you to manage them. Being aware that you are at an increased risk for coronary heart disease means that you can better manage your other risk factors, and should try even harder to manage them. So get to work!

HeartWire - Arrhythmia/EP
Depression and antidepressant use linked to sudden cardiac death
March 9, 2009 | Lisa Nainggolan

New York, NY - A new analysis has found that major depression predicted cardiovascular morbidity and mortality in women participating in the Nurses' Health Study [1]. The hazard ratios were strongest for fatal events and were driven by the association of depression—in particular, antidepressant use—with sudden cardiac death (SCD). Dr William Whang (Columbia University, New York, NY) and colleagues report their findings in the March 17, 2009 issue of the Journal of the American College of Cardiology.

But the authors and accompanying editorialists conclude that, at the present time, the benefits of appropriately prescribed antidepressant use likely outweigh the risk of SCD.

"The absence of proof that antidepressants might cause cardiac events is more relevant than conclusive proof that this effect is absent. Nevertheless, these findings are sufficiently sobering to warrant heightened clinical surveillance and to initiate studies to definitively address this relationship," say Drs Sanjiv M Narayan and Murray B Stein (University of California, San Diego [UCSD]) in an accompanying editorial comment [2].

Whang told heartwire that he believes the biggest clinical implication of this new study "is that management of coronary heart disease risk factors may be especially important among women with depressive symptoms."


Those using antidepressants three times more likely to suffer SCD

Whang et al prospectively studied 63 469 women in the Nurses' Health Study without baseline coronary disease, stroke, or malignancy. They studied depressive symptoms and a proxy variable for clinical depression consisting of severe symptoms and/or antidepressant use and their relationship to cardiovascular events.

Questionnaires in 1992, 1996, and 2000 assessed depressive symptoms, with major depression defined by a validated five-point mental-health-index score (MHI-5) of <53,>

Of the women, 7.9% had MHI-5 scores of <53,>

From 1996 onward, the proxy variable of severe symptoms and/or antidepressant use was most associated with SCD in multivariable models (HR 2.33), and the risk was primarily due to a specific relationship between antidepressant use and SCD (HR 3.34).

Narayan and Stein say the work of Whang et al stands out from previous research of this kind: "[This research] is particularly exciting. The authors should be congratulated for these important data on the etiologic role of depression and its treatment on cardiovascular outcomes in a very large cohort of healthy individuals."


Arrhythmia a possible mechanism, but further study needed

"This surprising results merits scrutiny," the editorialists say. Numerous pharmaceutical agents might contribute to arrhythmic mortality, and in the present study, 61% of subjects were using selective serotonin-reuptake inhibitors (SSRIs), while 39% used other, nonspecified antidepressants.

"Our study raises questions about the mechanism by which depression is associated with sudden cardiac death," Whang told heartwire. "This is not the first study to link risk of SCD to depression. Our study is consistent with prior analyses that have found an association between depressive symptoms and a higher mortality in patients with CHD, and it points to arrhythmia as a possible mechanism for this worse prognosis."

Narayan and Stein say: "It is unclear whether SSRI agents might cause [sudden cardiac arrest]. While cardiac events are well documented with . . . tricyclic antidepressants, evidence for a link with SSRIs is mixed."

"Moreover, it is quite possible that antidepressant use merely indicates that depression is of sufficient severity to merit treatment." It is well established that patients with depression after acute coronary syndrome, for example, are less likely to adhere to their cardiac medication regimens, note the UCSD doctors, although treating the depression improves adherence.

"Clearly, the burden of proof rests on confirming this association. There are abundant data attesting to the safety and efficacy of SSRIs in particular, and a relative paucity showing adverse cardiac effects," they conclude.

Whang et al agree: "Although antidepressant medication use might be a marker of worse depression, its specific association with elevated risk of SCD merits further study."



Twin study shows depression itself independently associated with heart disease

Chicago, IL - Separately, new research suggests that depression itself remains a significant contributor to incident heart disease after genetics and environmental, mental, and physical factors are controlled for [3]. The study, performed in 1200 male twins who served in the US military during the Vietnam War, was reported by Dr Jeffrey F Scherrer (Washington University School of Medicine and St Louis Veterans Affairs Medical Center) at the American Psychosomatic Society meeting last week

"In this study, we have demonstrated that exposure to depression is contributing to heart disease only in twins who have high genetic risk and who actually develop clinical depression," says Scherrer in a Washington University School of Medicine statement.

"In twins with high genetic risk common to depression and heart disease but who never develop depression itself, there was no increased risk for heart disease. The findings strongly suggest that depression itself independently contributes to risk for heart disease," he notes.


Narayan reports receiving speaking honoraria or serving as a consultant for St Jude Medical, Boston Scientific, Medtronic, Biosense-Webster, and Cambridge Heart. Stein receives or has received in the past three years research support from Eli Lilly and GlaxoSmithKline and is currently or in the past three years has been a consultant for BrainCells, Bristol-Myers Squibb, Eli Lilly, EPI-Q, Forest Laboratories, Hoffman La-Roche Pharmaceuticals, Integral Health Decisions, Jazz Pharmaceuticals, Johnson & Johnson, Mindsite, Pfizer, Sanofi-Aventis, Sepracor, Transcept Pharmaceuticals, and Virtual Reality Medical Center.
Sources
  1. Whang W, Kubzansky LD, Kawachi I, et al. Depression and risk of sudden cardiac death and coronary heart disease in women. Results from the Nurses' Health Study. J Am Coll Cardiol 2009; 53:950-958
  2. Narayan SM and Stein MB. Do depression or antidepressants increase cardiovascular mortality? The absence of proof might be more important than the proof of absence. J Am Coll Cardiol 2009; 53:959-961
  3. Dryden J. Depression increases risk for heart disease more than genetics or environment [press release]. March 3, 2009. Available at: http://mednews.wustl.edu/news/page/normal/13643.html?emailID=23300.

“Fat taxes” and the financial crisis

Moral of the story: The financial crisis may in fact be an overall positive factor in health care reform. Between the stimulus bill and the need for new funds at a state level there may be some movement here. This article talks about taxing food that are unhealthy while subsidizing healthy foods. This blog wholeheartedly supports such a measure, as long as it is applied towards food groups such as soda and candy and not unhealthy subsitance foods that would unfairly target poor populations that rely on such foods. A soda tax would go a long way towards keeping milk money for milk and budgets in the black.

“Fat taxes” and the financial crisis

The Lancet, Volume 373, Issue 9666, Pages 797 - 798, 7 March 2009

Karen McColl
Introducing taxes on junk foods and subsidies for healthy foods has been hotly debated in several countries. Could such moves build healthier populations and economies? Karen McColl reports.

The Governor of New York has proposed a new “soda tax” as part of measures to balance the state's budget following the shortfall caused by the financial crisis. The potential for so-called “fat taxes” on unhealthy foods—or subsidies on healthier foods—to improve public health has been the subject of much debate. Could these economic measures help respond to the financial crisis? There has been much talk about “green solutions” to the economic downturn. Could there be a role for public health solutions too?

In December, 2008, New York's Governor, David Paterson, proposed a new 18% tax on non-diet soft drinks as part of plans to tackle the state's largest ever budget deficit. State policy makers predict that the new tax—which, if approved, would come into force on June 1—would lead to a 5% drop in soft drink consumption and would also raise US$404 million for health-care spending in the first year.

The soft drinks tax is part of a package of proposals to tackle obesity in the state's children. But officials confirm that the projected $14 billion budget shortfall this year—caused by the meltdown in New York's financial services sector—presented a new opening for this type of tax.
The argument that using taxes or subsidies to influence food prices could be a valuable tool in preventing obesity and other diet-related disease in industrialised countries is not new. There has been debate in several countries—including Denmark, France, New Zealand, and the UK—about the possibilities for using taxes or subsidies in this way.

In economic terms, so-called “fat taxes” or “junk food taxes”—like taxes on tobacco or alcohol—make sense. The costs to society resulting from obesity and other diet-related diseases are immense—in terms of health-care costs, sickness absence, welfare payments, and lost tax revenue—and these are not reflected in food pricing. In New York state alone, for example, treatment for obesity-related health problems costs $6·1 billion each year.

Research suggests that, hypothetically, taxes do have considerable potential to influence food choices, change diets, and improve health. In the UK, for example, Oliver Mytton and colleagues modelled three different tax scenarios and concluded that a carefully designed tax could avert up to 3200 deaths from cardiovascular disease each year. A report published in 2007 by the Danish Academy of Technical Sciences concluded that a tax exemption for “healthy” products (including fruit, vegetables, rice, pasta, potatoes, and fish products) combined with a 30% tax increase on “unhealthy” products would bring the Danish population's diet in line with national dietary guidelines. The Academy's report ignited widespread debate and the Danish Government established a new Commission on Disease Prevention, which is due to report on this issue later this month.

But research also highlights that poorly designed measures could have unintended—and even counter-productive—effects. This is because changes in the price of one food product can affect the consumption of other products that are either eaten with or instead of that food. Many foods are related to other food products in this way and it can be difficult to predict these effects. In one of the scenarios tested by Mytton and colleagues, beneficial reductions in saturated fat intakes were partly offset by an increase in salt consumption and decreases in polyunsaturated and monounsaturated fat intakes. They concluded that the taxes proposed under that particular scenario would do more harm than good and called for new taxes to be carefully targeted.

The most controversial aspect of the “fat tax” debate is that any new tax on unhealthy foods is likely to hit poorest groups hardest. A “fat tax” would be regressive—in other words, low-income households would spend a higher proportion of their income on the tax than higher income households. The potential effect of New York's proposed “soda tax” on the state's poorest citizens, for example, has been heavily criticised. “The Governor of New York announced a few weeks ago that he was not going to impose any taxes on the rich. Yet the same governor seems to have no qualms imposing regressive taxes on the African American poor”, said Adam Drewnowski, director of the University of Washington's Center for Obesity Research. “If you look at the map of soft drinks consumption in NYC and the map of poverty you will see that they are—in fact—one and the same.”

Very low LDL and normal BP result in slowest progression of atherosclerosis

Moral of the story: 2 thing - Blood Pressure, LDL. Worry about those two things. Get them back to normal and you will go a long way towards preventing heart disease.

Heartwire - Clinical cardiology
Very low LDL and normal BP result in slowest progression of atherosclerosis
March 23, 2009 | Michael O'Riordan

Cleveland, OH - Patients with coronary artery disease (CAD) who reduce LDL cholesterol to very low levels and achieve a normal systolic blood pressure have the slowest progression of coronary atherosclerosis as assessed by intravascular ultrasound (IVUS), a new study has shown [1]. The findings, according to investigators, support the need for intensive management of global risk in patients with CAD.

"What's happened in recent years with the advent of more potent statins and all the education done around that is that getting people to LDL goal is achieved fairly well," senior investigator Dr Steven Nissen (Cleveland Clinic, OH) told heartwire. "But getting people to dual goals is not done well around the country. We wanted to tell people that there really is some pretty good evidence here that if you get your blood pressure down to normal and your LDL down below 70, this is a disease that can not only be halted, but potentially can even regress."

The results of the study are published in the March 24, 2009 issue of the Journal of the American College of Cardiology.


Seven studies rolled into one

To clarify the relationship between LDL cholesterol and systolic blood pressure and their effects on coronary plaque progression, the researchers, led by Dr Adnan Chhatriwalla (Cleveland Clinic) studied 3437 patients with established CAD enrolled in seven clinical trials. The studies included REVERSAL, CAMELOT, ACTIVATE, ASTEROID, ILLUSTRATE, PERISCOPE, and STRADIVARIUS, a group of trials that investigated statins, acyl coenzyme A:cholesterol acyltransferase (ACAT) and cholesteryl ester transfer protein (CETP) inhibitors, rimonabant, ACE inhibitors, and calcium-channel blockers, among others.

Patients were stratified into four groups based on their average on-treatment LDL-cholesterol levels and systolic blood pressure:

  • LDL cholesterol <70 mg/dL and systolic blood pressure <120 mm Hg.
  • LDL cholesterol <70 mg/dL and systolic blood pressure >120 mm Hg.
  • LDL cholesterol >70 mg/dL and systolic blood pressure <120 mm Hg.
  • LDL cholesterol >70 mg/dL and systolic blood pressure >120 mmHg.

Changes in atheroma burden were monitored by IVUS, which was measured at baseline and at 18 to 24 months.

Patients with very low LDL-cholesterol levels and normal systolic blood pressure, group 1, had the least progression in percent atheroma volume (PAV) and total atheroma volume (TAV). In addition, these patients also had less frequent atheroma progression and more frequent regression. In patients with systolic blood pressure >120 mm Hg who still had very low LDL cholesterol levels, group 2, less progression of PAV and TAV was also observed.

"It really makes a big difference if you can get both down," said Nissen. "It's a big payoff for patients if physicians are diligent about getting LDL and blood pressure under control."

Among patients with LDL-cholesterol levels >70 mg/dL, normal systolic blood pressure was associated with no greater reduction in PAV or TAV, suggesting that lipid lowering has a larger impact than blood-pressure control on plaque progression, findings supported by recent clinical trials.

The findings challenge current treatment recommendations for hypertension, noted Nissen, and he recommends treating prehypertensive patients with coronary disease, those with pressures of 120 to 139 mm Hg systolic or 80 to 89 mm Hg diastolic. In the CAMELOT study, he points out, the calcium-channel blocker amlodipine decreased the risk of cardiovascular events in patients with CAD and normal blood pressure, as did the ACE inhibitor enalapril, but to a lesser extent.

"Remember that these are all people who have coronary artery disease," said Nissen. "These are not your typical primary-prevention patients with hypertension. They already have atherosclerotic disease in their coronaries. We think the evidence is pretty strong that if you already have plaques in your coronaries, you really to have a lower blood-pressure target. . . . Our IVUS data suggest that there is opportunity here to help patients."

Nissen admitted that the issue needs to be studied further and that the ongoing AQUARIUS study will assess changes in atherosclerotic disease progression with aliskiren (Tekturna, Novartis) when given in addition to standard therapy in CAD patients with prehypertension.


More data still needed

In an editorial accompanying the published study, Drs Jonathan Tobis and Alice Perlowski (University of California, Los Angeles) write that human and animal data make clear that a combination of aggressive lipid and blood-pressure control are necessary for a maximum attenuation of plaque progression, improved endothelial function, and reduced inflammation caused by oxidative stress [2].

Regarding the treatment of prehypertensive patients, Tobis and Perlowski write that a lack of data has contributed to a delayed acceptance of the need for drug therapy. In addition to AQUARIUS, the ongoing SPRINT, which is comparing intensive blood-pressure control (<120>130 mm Hg who have one additional risk factor, will help answer those questions.

The editorialists note that plaque progression/regression on IVUS is helpful in determining whether or not clinicians are helping their patients, but hard clinical end points are still needed, especially as they are shown to correspond with predictions based on the IVUS surrogates. Until then, "conclusions derived from these trials should be considered inferential, to be used as guides for future trials focused on clinical-outcomes measures," they write.

Asked about the polypill, Nissen told heartwire that he was not an initial fan, but with these and other data, he is starting to warm up to it. "The idea of having something that you go and get for $10 for three months that would control your blood pressure and your lipids, this study makes the case that it might make some sense."

New results about a polypill approach for primary prevention, combining a BP-lowering drug, a statin, and aspirin in a single pill, will be presented at the American College of Cardiology 2009 meeting next week.

Nissen reports receiving research support from AstraZeneca, Eli Lilly, Pfizer, Takeda, Sankyo, and Sanofi-Aventis and that he donates honoraria, consulting fees, and other payments directly to charity. Chhattriwalla reports no conflicts.
Sources
  1. Chhatriwalla AK, Nicholls SJ, Wang TH, et al. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis. J Am Coll Cardiol 2009; 53: 1110-1115.
  2. Tobis JM, Perlowski A. Atheroma volume by intravascular ultrasound as a surrogate for clinical endpoints. J Am Coll Cardiol 2009; 53: 1116-1118.

Meat Intake and Mortality

Moral of the story: Reducing meat consumption may not be a bad idea. You do not necessarily have to eliminate it from your diet, but maybe you shouldn't have filet mignon 7 days a week. The study shows that those people eating the most red and processed meat were more likely to die than those eating the least amount of red and processed meat. Causes of mortality were cancer and cardiovascular related. This is a gigantic study so trust the results.

Meat Intake and Mortality

A Prospective Study of Over Half a Million People

Rashmi Sinha, PhD; Amanda J. Cross, PhD; Barry I. Graubard, PhD; Michael F. Leitzmann, MD, DrPH; Arthur Schatzkin, MD, DrPH

Arch Intern Med. 2009;169(6):562-571.

Background High intakes of red or processed meat may increase the risk of mortality. Our objective was to determine the relations of red, white, and processed meat intakes to risk for total and cause-specific mortality.

Methods The study population included the National Institutes of Health–AARP (formerly known as the American Association of Retired Persons) Diet and Health Study cohort of half a million people aged 50 to 71 years at baseline. Meat intake was estimated from a food frequency questionnaire administered at baseline. Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) within quintiles of meat intake. The covariates included in the models were age, education, marital status, family history of cancer (yes/no) (cancer mortality only), race, body mass index, 31-level smoking history, physical activity, energy intake, alcohol intake, vitamin supplement use, fruit consumption, vegetable consumption, and menopausal hormone therapy among women. Main outcome measures included total mortality and deaths due to cancer, cardiovascular disease, injuries and sudden deaths, and all other causes.

Results There were 47 976 male deaths and 23 276 female deaths during 10 years of follow-up. Men and women in the highest vs lowest quintile of red (HR, 1.31 [95% CI, 1.27-1.35], and HR, 1.36 [95% CI, 1.30-1.43], respectively) and processed meat (HR, 1.16 [95% CI, 1.12-1.20], and HR, 1.25 [95% CI, 1.20-1.31], respectively) intakes had elevated risks for overall mortality. Regarding cause-specific mortality, men and women had elevated risks for cancer mortality for red (HR, 1.22 [95% CI, 1.16-1.29], and HR, 1.20 [95% CI, 1.12-1.30], respectively) and processed meat (HR, 1.12 [95% CI, 1.06-1.19], and HR, 1.11 [95% CI 1.04-1.19], respectively) intakes. Furthermore, cardiovascular disease risk was elevated for men and women in the highest quintile of red (HR, 1.27 [95% CI, 1.20-1.35], and HR, 1.50 [95% CI, 1.37-1.65], respectively) and processed meat (HR, 1.09 [95% CI, 1.03-1.15], and HR, 1.38 [95% CI, 1.26-1.51], respectively) intakes. When comparing the highest with the lowest quintile of white meat intake, there was an inverse association for total mortality and cancer mortality, as well as all other deaths for both men and women.

Conclusion Red and processed meat intakes were associated with modest increases in total mortality, cancer mortality, and cardiovascular disease mortality.


Author Affiliations: Nutritional Epidemiology Branch (Drs Sinha, Cross, Leitzmann, and Schatzkin) and Biostatistics Branch (Dr Graubard), Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Rockville, Maryland.

Wednesday, March 18, 2009

Modest reductions in dietary salt would reap great benefits

Moral of the story: Add just a little less salt while cooking, add even less while eating and it will go a long way.

Modest reductions in dietary salt would reap great benefits
March 17, 2009 | Lisa Nainggolan

Palm Harbor, FL - US researchers say even a small reduction in the amount of salt in the daily diet would have a huge public-health impact. Dr Kirsten Bibbins-Domingo (University of California, San Francisco) and colleagues calculate that cutting just 1 g of salt a day would prevent a quarter of a million new heart-disease cases and 200 000 deaths from any cause over a decade [1].

Bibbins-Domingo told heartwire that "everyone would benefit, but certain groups gain more." These include African Americans, women, and those under 65, she noted. Americans currently eat 9 to 12 g of salt per day, an amount far in excess of the 5 to 6 g per day that is recommended by most health organizations, she said. She reported the new findings in a poster at the AHA 49th Annual Conference on Cardiovascular Disease Epidemiology and Prevention last week.

She feels strongly that regulatory efforts will be key to tackling this problem, because 80% of the salt in the US—and other Western nations' diets—comes from processed and prepared foods. "We can't just keep telling patients to get rid of the salt shaker, because that has very little effect."

With these very small changes . . . we will not change the taste of foods or the profit margins of the food industry, but it would be a great benefit for public health.

"We think our study lends support to the idea that this is an area that's really a prime target for public-health types of intervention, including regulatory efforts to restrict salt or force labeling of foods based on their salt content. We hope this would encourage efforts on the part of industry to reduce salt. The experience in other countries suggests that with these very small changes we are describing, we will not change the taste of foods or the profit margins of the food industry, but it would be a great benefit for public health."


A 3-g daily reduction in salt would give same benefits as eliminating smoking

Bibbins-Domingo et al used the Coronary Heart Disease Policy Model, a computer simulation of heart disease in the US adult population, and an extension that assesses stroke, to evaluate the impact of hypothetical policy changes on the health of the nation.

They estimated the impact of an immediate reduction of daily salt intake by 0 to 6 g on the incidence of cardiovascular disease and deaths between 2010 and 2019. In that period, the model suggests that more than 800 000 life-years could be saved for each gram of salt lowered.

"Others have estimated the population benefits of salt reduction; our findings are consistent with these studies and extend them in important ways," she and her colleagues note.

A 3-g daily reduction in the amount of salt consumed would provide morbidity and mortality benefits "on the same order of magnitude as if we could eliminate smoking in the population, and that's a really important point to make," she told heartwire. Such a reduction would result in 6% fewer cases of new heart disease, 8% fewer MIs, and 3% fewer deaths.

Even larger health benefits are projected for African Americans, she says, who are more likely to have high blood pressure and whose blood pressure may be more sensitive to salt: new heart-disease cases would be reduced by 10%, MIs by 13%, and deaths by 6%. Other groups who would gain include women, because of reductions in stroke—as high blood pressure is the major risk factor for stroke—and young people (under 65), who would benefit from a reduction in premature death, because often high blood pressure is the only risk factor in this group, she notes.

Bibbins-Domingo says consumer awareness is also important, so that individuals make more effort to reduce salt in their diets. Experiences in other countries suggest that the combination of government regulations, labeling requirements, voluntary efforts on the part of industry, and increasing consumer awareness of the dangers of consuming too much salt can, in concert, achieve worthwhile improvements. In the UK, for example, a combination of the above managed to achieve a 10% reduction in salt intake, she notes.

"We have to appreciate the scope of this problem and realize that efforts are needed on all these levels," she concludes.

Source
  1. Bibbins-Domingo, Chertow G, Moran A et al. Population reductions in coronary heart disease associated with modest increases in salt intake: projections from the CHD policy model. AHA 49th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; March 10-14, 2009; Palm Harbor, FL. Abstract P51.